| Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria M Balwani, E Sardh, P Ventura, PA Peiró, DC Rees, U Stölzel, DM Bissell, ... New England journal of medicine 382 (24), 2289-2301, 2020 | 446 | 2020 |
| EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks L Gouya, P Ventura, M Balwani, DM Bissell, DC Rees, U Stölzel, ... Hepatology 71 (5), 1546-1558, 2020 | 142 | 2020 |
| Isoprinosine affects serum cytokine levels in healthy adults M Petrova, D Jelev, A Ivanova, Z Krastev Journal of Interferon & Cytokine Research 30 (4), 223-228, 2010 | 92 | 2010 |
| C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria A Ivanova, N von Ahsen, D Adjarov, Z Krastev, M Oellerich, E Wieland Hepatology 30 (6), 1531-1532, 1999 | 48 | 1999 |
| New electrochemical methods of determining anti-oxidant activity of blood and blood fractions KZ Brainina, LV Alyoshina, EL Gerasimova, YE Kazakov, YB Beykin, ... Electroanalysis 21, 618-624, 2009 | 33 | 2009 |
| Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report R Tomova, K Antonov, A Ivanova, JJL Jacobs, JW Koten, W Den Otter, ... Anticancer research 29 (12), 5241-5244, 2009 | 23 | 2009 |
| Alteration in salivary components of children with allergic asthma A Krasteva, P Perenovska, A Ivanova, I Altankova, T Bocheva, ... Biotechnology & Biotechnological Equipment 24 (2), 1866-1869, 2010 | 19 | 2010 |
| GS-14-ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic … M Balwani, L Gouya, D Rees, P Stein, U Stölzel, P Aguilera, DM Bissell, ... Journal of Hepatology 70 (1), e81-e82, 2019 | 15 | 2019 |
| An investigation of the effect of methyl cellulose and sodium polyacrylate on the hydrosorption properties of a vulcanisate based on chloroprene rubber AV Ivanova, NF Ushmarin, EN Egorov, SI Sandalov, NI Kol’tsov International Polymer Science and Technology 45 (7), 311-314, 2018 | 15 | 2018 |
| Presence of helicobacter pylori in patients with oral malodor A Krasteva, A Kisselova, V Dineva, VE Panov, A Ivanova, Z Krastev J of IMAB 19 (4), 419-421, 2013 | 13 | 2013 |
| Folic acid and vitamin B12 levels in Bulgarian patients with burning mouth syndrome A Krasteva, A Kisselova, V Dineva, A Ivanova, Z Krastev J of IMAB 19 (4), 422-425, 2013 | 12 | 2013 |
| Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network PE Stein, Y Edel, R Mansour, RA Mustafa, S Sandberg, ... Journal of Inherited Metabolic Disease 46 (4), 662-674, 2023 | 11 | 2023 |
| Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis) I Borisov, G Kolarov, S Bobcheva, A Ivanova Akusherstvo i ginekologiia 44, 17-20, 2005 | 11 | 2005 |
| EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms D Cassiman, R Kauppinen, S Monroy, MJ Lee, HL Bonkovsky, M Thapar, ... Journal of Inherited Metabolic Disease 45 (6), 1163-1174, 2022 | 10 | 2022 |
| Azithromycin decrease saliva calprotectin in patients with periodontal diseases V Panov, A Krasteva, AZ Krasteva, A Ivanova, A Panov, Z Krastev Journal of IMAB–Annual Proceeding Scientific Papers 20 (1), 464-468, 2014 | 10 | 2014 |
| Psoriatic patients and salivary components A Krasteva, I Grozdev, A Ivanova, I Altankova, S Bocheva, A Kisselova, ... Oral Health and Dental Management in the Black Sea Countries 8 (2), 12-15, 2009 | 10 | 2009 |
| Hepatitis C virus infection: a possible promoting agent in porphyria cutanea tarda. K Antonov, Z Krastev, P Teoharov, E Zaharieva, A Alexiev, A Ivanova, ... The Italian journal of gastroenterology 28 (9), 482-486, 1996 | 9 | 1996 |
| Diagnostic dilemmas in hepatitis C virus infection for hemodialysis patients RT Komitova, MV Atanasova, TA Pavlova, MS Nyagolov, AV Ivanova Folia Medica 59 (1), 70, 2017 | 8 | 2017 |
| Evaluation of HBV DNA levels in saliva in subjects with different viremia as well as during peginterferon α-2a therapy A Krasteva, VE Panov, D Jelev, K Antonov, A Ivanova, Z Krastev J of IMAB 19 (4), 355-358, 2013 | 8 | 2013 |
| Potentiometric method of antioxidant activity measuring: the estimate of main metrological characteristics EN Sharafutdinova, OV Inzhevatova, NV Tobolkina, AV Ivanova, ... Zavodskaia laboratoriia. Diagnostika materialov [Industrial laboratory …, 2008 | 8 | 2008 |
